The IRC Network Biotechnology Thematic Group's goal is to contribute to the promotion of innovation in the European Biotechnology sector through technology transfer. More
Developer of cancer chemotherapeutics via novel proprietary drug derivatives that have highly specific anticancer activity with minimal systemic toxicities. More
QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
Kalight is devoted to developing patents dealing with viral CNS conditions and seeking licensees and partnerships. Currently, it is marketing its patent for certain herpes neurological conditions. More
A leading R&D consortium providing access to unique world-class expertise in biotech fields including pharmaceuticals, biomedics/healthcare, food and agriculture. More
The company positions itself as a distributor for API's and hospital specialty compounds: ATU's, generic portfolio for oncology, anti-emesis, pain management as well as intensive care . More